» Articles » PMID: 29189379

Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases: A Systematic Review and Meta-analysis

Abstract

Objective: To examine the impact of surgical margin width on survival following R0 hepatic resection for colorectal metastases (CRLM).

Summary Of Background Data: Although negative resection margin is considered of paramount importance for the prognosis of patients with colorectal liver metastases, optimal resection margin width remains controversial.

Methods: Eligible studies examining the association between margin status after R0 hepatic resection for CRLM and survival, including overall survival (OS) and disease-free survival (DFS) were sought using the Medline, Cochrane, and EMBASE databases. Random-effects models were used for the calculation of pooled relative risks (RRs) with their 95% confidence intervals (95% CIs).

Results: Thirty-four studies were deemed eligible for inclusion representing a cohort of 11,147 hepatic resections. Wider resection margin (>1 vs <1 cm) was significantly associated with improved OS at 3 years (pooled RR = 0.86, 95% CI: 0.79-0.95), 5 years (pooled RR = 0.91, 95% CI: 0.85-0.97), and 10 years (pooled RR = 0.94, 95% CI: 0.88-1.00). Similarly, DFS was positively associated with >1 cm resection margin at 3, 5, and 10 years. Interestingly, >1 mm (vs <1 mm) resection margin was significantly associated with improved OS at all-time points. Meta-regression analyses did not reveal any significant modifying role of the study features under investigation, such as the administration of neoadjuvant/adjuvant therapy.

Conclusions: Importantly, our findings suggest that while a >1 mm margin is associated with better prognosis than a submillimeter margin, achieving a margin >1 cm may result in even better oncologic outcomes and should be considered if possible.

Citing Articles

Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).

Jin Z, Li Y, Yi H, Wang M, Wang C, Du S Int J Oncol. 2025; 66(3).

PMID: 39950314 PMC: 11844340. DOI: 10.3892/ijo.2025.5728.


Dual-Time-Point Radiomics for Prognosis Prediction in Colorectal Liver Metastasis Treated with Neoadjuvant Therapy Before Radical Resection: A Two-Center Study.

Li Z, Zhang J, Tian S, Sun C, Ma Y, Ye Z Ann Surg Oncol. 2025; .

PMID: 39907877 DOI: 10.1245/s10434-025-16941-6.


The Effect of Hepatic Surgical Margins of Colorectal Liver Metastases on Prognosis: A Systematic Review and Meta-Analysis.

Paramythiotis D, Karlafti E, Tsavdaris D, Apostolidou Kiouti F, Haidich A, Ioannidis A J Clin Med. 2025; 13(24.

PMID: 39768699 PMC: 11727772. DOI: 10.3390/jcm13247776.


Comparative Evaluation of CEUS and CECT in the Detection of Liver Metastases of Middle and Low Rectal Cancer.

Liu Y, Lun H, Huang X, Huang J, Zhu S Int J Gen Med. 2024; 17:5817-5824.

PMID: 39654984 PMC: 11627102. DOI: 10.2147/IJGM.S491165.


Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.

Zheng J, Wang T, Wang H, Yan B, Lai J, Qiu K Ann Surg Oncol. 2024; 32(2):771-782.

PMID: 39614006 DOI: 10.1245/s10434-024-16519-8.